Exclusives | Asia

Dr Reddy’s rolls out new generic Ozempic brands to ease Obeda supply hit

23 October 2026, 2:52 pm

1 min read

FILE PHOTO: Scientific model of the molecule semaglutide which is the active ingredient in Novo Nordisk's mega-blockbuster diabetes drug Ozempic and weight-loss drug Wegovy sits in the office of Mads Krogsgaard Thomsen in Hellerup, Denmark, October 3, 2023. REUTERS/Ali Withers/File Photo

Dr Reddy’s Laboratories has expanded its portfolio of generic versions of Ozempic with two new brands to fill a supply-chain hit to its original Obeda injections, product photographs and marketing materials reviewed show. Shares in Dr Reddy’s fell by as much as 2% after the Reuters report.